Balyasny Asset Management LLC Prime Medicine, Inc. Transaction History

Balyasny Asset Management LLC

  • $63.6 Billion
  • Q4 2024

A detailed history of Balyasny Asset Management LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 16,342 shares of PRME stock, worth $48,535. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,342
Holding current value
$48,535
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$2.64 - $4.46 $43,142 - $72,885
16,342 New
16,342 $47,000
Q2 2024

Aug 14, 2024
BUY
$4.3 - $8.03 $52,034 - $97,171
12,101 New
12,101 $62,000

Others Institutions Holding PRME

# of Institutions
136
Shares Held
60.9M
Call Options Held
42.6K
Put Options Held
173K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $284M
More about PRME
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email